239 related articles for article (PubMed ID: 28152117)
1. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer.
Aydil U; Akmansu M; Gumusay Ö; Bakkal FK; Yazıcı Ö; Kızıl Y; Köybaşıoğlu A; Yıldız R; Büyükberber S; İnal E
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2795-803. PubMed ID: 26683470
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
6. Long-term functional outcome after laryngeal cancer treatment.
Anschuetz L; Shelan M; Dematté M; Schubert AD; Giger R; Elicin O
Radiat Oncol; 2019 Jun; 14(1):101. PubMed ID: 31186027
[TBL] [Abstract][Full Text] [Related]
7. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
9. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
10. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
11. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.
Wolf GT; Bradford CR; Urba S; Smith A; Eisbruch A; Chepeha DB; Teknos TN; Worden F; Dawson L; Terrell JE; Hogikyan ND
Laryngoscope; 2002 Aug; 112(8 Pt 1):1351-6. PubMed ID: 12172244
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
Hall SF; Griffiths RJ
Head Neck; 2018 May; 40(5):1024-1033. PubMed ID: 29412495
[TBL] [Abstract][Full Text] [Related]
13. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
14. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
[TBL] [Abstract][Full Text] [Related]
16. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
17. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]